3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Prostatic Neoplasms
2
Head and Neck Neoplasms
2
Colorectal Neoplasms
2
Thrombosis
1
Squamous Cell Carcinoma of Head and Neck
1
Sexuality
1
Sexual Dysfunction, Physiological
1
Salivary Gland Neoplasms
1
Radiation Injuries
1
Protein Metabolism
1
Pain
1
Neoplasms
1
Multiple Endocrine Neoplasia Type 1
1
Mucositis
1
Malnutrition
1
Hemorrhage
1
Glioblastoma
1
Erectile Dysfunction
1
Disease
1
Diabetes Insipidus
1
Interventions
apixaban
3
Warfarin
2
Dalteparin
2
Aspirin
2
salicylhydroxamic acid
1
fluorescein isothiocyanate-keyhole limpet hemocyanin
1
edoxaban
1
Simvastatin
1
Rivaroxaban
1
Radiotherapy, Conformal
1
Paclitaxel
1
Observation
1
Injections
1
Fondaparinux
1
Enoxaparin
1
Docetaxel
1
Data Collection
1
Dabigatran
1
Clopidogrel
1
Arginine Vasopressin
1
Arginine
1
Anticoagulants
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Thrombosis
×
Arginine
×
Clear all
NCT05293041
2025-03-06
ARG-01
Sahlgrenska University Hospital
Phase 4
Completed
248 enrolled